{"title":"造血干细胞移植(HSCT)后侵袭性肺曲霉病(IPA):免疫功能障碍是否起作用?","authors":"A. Kuwal, N. Dutt, N. Chauhan","doi":"10.29245/2689-9981/2018/2.1111","DOIUrl":null,"url":null,"abstract":"Invasive pulmonary aspergillosis (IPA) is a major cause of morbidity and mortality among patients undergoing hematopoietic stem cell transplant (HSCT). The majority of cases are detected during the period of neutropenia (following conditioning regimen) or immunosuppression (treatment of graft versus host disease). Development of IPA after one-year postHSCT is extremely rare. Here, we report a case of a 43-year-old male who developed IPA two years after an allogenic stem cell transplant and 406 days after stopping the immunosuppressive medication.","PeriodicalId":16100,"journal":{"name":"Journal of Infectiology","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Invasive Pulmonary Aspergillosis (IPA) Post Hematopoietic Stem Cell Transplant (HSCT): Is Immunological Dysfunction Play a Role?\",\"authors\":\"A. Kuwal, N. Dutt, N. Chauhan\",\"doi\":\"10.29245/2689-9981/2018/2.1111\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Invasive pulmonary aspergillosis (IPA) is a major cause of morbidity and mortality among patients undergoing hematopoietic stem cell transplant (HSCT). The majority of cases are detected during the period of neutropenia (following conditioning regimen) or immunosuppression (treatment of graft versus host disease). Development of IPA after one-year postHSCT is extremely rare. Here, we report a case of a 43-year-old male who developed IPA two years after an allogenic stem cell transplant and 406 days after stopping the immunosuppressive medication.\",\"PeriodicalId\":16100,\"journal\":{\"name\":\"Journal of Infectiology\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Infectiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.29245/2689-9981/2018/2.1111\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infectiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29245/2689-9981/2018/2.1111","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Invasive Pulmonary Aspergillosis (IPA) Post Hematopoietic Stem Cell Transplant (HSCT): Is Immunological Dysfunction Play a Role?
Invasive pulmonary aspergillosis (IPA) is a major cause of morbidity and mortality among patients undergoing hematopoietic stem cell transplant (HSCT). The majority of cases are detected during the period of neutropenia (following conditioning regimen) or immunosuppression (treatment of graft versus host disease). Development of IPA after one-year postHSCT is extremely rare. Here, we report a case of a 43-year-old male who developed IPA two years after an allogenic stem cell transplant and 406 days after stopping the immunosuppressive medication.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
